Literature DB >> 26001789

Hospital-associated venous thromboembolism in pediatrics: a systematic review and meta-analysis of risk factors and risk-assessment models.

Arash Mahajerin1, Brian R Branchford2, Ernest K Amankwah3, Leslie Raffini4, Elizabeth Chalmers5, C Heleen van Ommen6, Neil A Goldenberg7.   

Abstract

Hospital-associated venous thromboembolism, including deep vein thrombosis and pulmonary embolism, is increasing in pediatric centers. The objective of this work was to systematically review literature on pediatric hospital-acquired venous thromboembolism risk factors and risk-assessment models, to inform future prevention research. We conducted a literature search on pediatric venous thromboembolism risk via PubMed (1946-2014) and Embase (1980-2014). Data on risk factors and risk-assessment models were extracted from case-control studies, while prevalence data on clinical characteristics were obtained from registries, large (n>40) retrospective case series, and cohort studies. Meta-analyses were conducted for risk factors or clinical characteristics reported in at least three studies. Heterogeneity among studies was assessed with the Cochran Q test and quantified by the I(2) statistic. From 394 initial articles, 60 met the final inclusion criteria (20 case-control studies and 40 registries/large case series/cohort studies). Significant risk factors among case-control studies were: intensive care unit stay (OR: 2.14, 95% CI: 1.97-2.32); central venous catheter (OR: 2.12, 95% CI: 2.00-2.25); mechanical ventilation (OR: 1.56, 95%CI: 1.42-1.72); and length of stay in hospital (per each additional day, OR: 1.03, 95% CI: 1.03-1.03). Three studies developed/applied risk-assessment models from a combination of these risk factors. Fourteen significant clinical characteristics were identified through non-case-control studies. This meta-analysis confirms central venous catheter, intensive care unit stay, mechanical ventilation, and length of stay as risk factors. A few pediatric hospital-acquired venous thromboembolism risk scores have emerged employing these factors. Prospective validation is necessary to inform risk-stratified prevention trials. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Year:  2015        PMID: 26001789      PMCID: PMC5004420          DOI: 10.3324/haematol.2015.123455

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  19 in total

1.  Impact of obesity on the risk of venous thromboembolism in an inpatient pediatric population.

Authors:  Sean Stokes; Patrick Breheny; Aurelia Radulescu; Vlad Calin Radulescu
Journal:  Pediatr Hematol Oncol       Date:  2014-03-31       Impact factor: 1.969

Review 2.  Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.

Authors:  Reineke A Schoot; Leontien C M Kremer; Marianne D van de Wetering; Cornelia H van Ommen
Journal:  Cochrane Database Syst Rev       Date:  2013-09-11

3.  Increased use of enoxaparin in pediatric trauma patients.

Authors:  Johanna R Askegard-Giesmann; Sarah H O'Brien; Wei Wang; Brian D Kenney
Journal:  J Pediatr Surg       Date:  2012-05       Impact factor: 2.545

4.  Incidence and risk factors associated with venous thrombotic events in pediatric intensive care unit patients.

Authors:  Renee A Higgerson; Karla A Lawson; Leeann M Christie; Ann-Marie Brown; Jennifer A McArthur; Balagangadhar R Totapally; Sheila J Hanson
Journal:  Pediatr Crit Care Med       Date:  2011-11       Impact factor: 3.624

Review 5.  Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; John W Eikelboom; Michael K Gould; David A Garcia; Mark Crowther; M Hassan Murad; Susan R Kahn; Yngve Falck-Ytter; Charles W Francis; Maarten G Lansberg; Elie A Akl; Jack Hirsh
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

6.  Development of a new risk score for hospital-associated venous thromboembolism in noncritically ill children: findings from a large single-institutional case-control study.

Authors:  Christie M Atchison; Shilpa Arlikar; Ernest Amankwah; Irmel Ayala; Laurie Barrett; Brian R Branchford; Michael Streiff; Clifford Takemoto; Neil A Goldenberg
Journal:  J Pediatr       Date:  2014-07-23       Impact factor: 4.406

Review 7.  Making health care safer: a critical analysis of patient safety practices.

Authors:  K G Shojania; B W Duncan; K M McDonald; R M Wachter; A J Markowitz
Journal:  Evid Rep Technol Assess (Summ)       Date:  2001

8.  Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007.

Authors:  Leslie Raffini; Yuan-Shung Huang; Char Witmer; Chris Feudtner
Journal:  Pediatrics       Date:  2009-09-07       Impact factor: 7.124

Review 9.  Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies.

Authors:  Guy Young; Manuela Albisetti; Mariana Bonduel; Leonardo Brandao; Anthony Chan; Frauke Friedrichs; Neil A Goldenberg; Eric Grabowski; Christine Heller; Janna Journeycake; Gili Kenet; Anne Krümpel; Karin Kurnik; Aaron Lubetsky; Christoph Male; Marilyn Manco-Johnson; Prasad Mathew; Paul Monagle; Heleen van Ommen; Paolo Simioni; Pavel Svirin; Daniela Tormene; Ulrike Nowak-Göttl
Journal:  Circulation       Date:  2008-09-08       Impact factor: 29.690

10.  Risk-prediction tool for identifying hospitalized children with a predisposition for development of venous thromboembolism: Peds-Clot clinical Decision Rule.

Authors:  A A Sharathkumar; A Mahajerin; L Heidt; K Doerfer; M Heiny; T Vik; R Fallon; A Rademaker
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

View more
  25 in total

1.  Association of infections and venous thromboembolism in hospitalized children with nephrotic syndrome.

Authors:  Shannon L Carpenter; Jennifer Goldman; Ashley K Sherman; David T Selewski; Mahmoud Kallash; Cheryl L Tran; Meredith Seamon; Chryso Katsoufis; Isa Ashoor; Joel Hernandez; Katarina Supe-Markovina; Cynthia D'alessandri-Silva; Nilka DeJesus-Gonzalez; Tetyana L Vasylyeva; Cassandra Formeck; Christopher Woll; Rasheed Gbadegesin; Pavel Geier; Prasad Devarajan; William E Smoyer; Bryce A Kerlin; Michelle N Rheault
Journal:  Pediatr Nephrol       Date:  2018-09-07       Impact factor: 3.714

2.  Early discharge in selected patients with low-grade renal trauma.

Authors:  Lucas Freton; Lucie-Marie Scailteux; Marine Hutin; Jonathan Olivier; Quentin Langouet; Marina Ruggiero; Ines Dominique; Clémentine Millet; Sébastien Bergerat; Paul Panayatopoulos; Reem Betari; Xavier Matillon; Ala Chebbi; Thomas Caes; Pierre-Marie Patard; Nicolas Szabla; Nicolas Brichart; Axelle Boehm; Laura Sabourin; Kerem Guleryuz; Charles Dariane; Cédric Lebacle; Jérome Rizk; Alexandre Gryn; François-Xavier Madec; François-Xavier Nouhaud; Xavier Rod; Emmanuel Oger; Gaelle Fiard; Karim Bensalah; Benjamin Pradere; Benoit Peyronnet
Journal:  World J Urol       Date:  2019-06-28       Impact factor: 4.226

3.  A New Risk Assessment Model for Hospital-Acquired Venous Thromboembolism in Critically Ill Children: A Report From the Children's Hospital-Acquired Thrombosis Consortium.

Authors:  Julie Jaffray; Arash Mahajerin; Brian Branchford; Anh Thy H Nguyen; E Vincent S Faustino; Michael Silvey; Stacy E Croteau; John H Fargo; James D Cooper; Nihal Bakeer; Neil A Zakai; Amy Stillings; Emily Krava; Ernest K Amankwah; Guy Young; Neil A Goldenberg
Journal:  Pediatr Crit Care Med       Date:  2022-01-01       Impact factor: 3.971

4.  Direct oral anticoagulants versus standard anticoagulation in children treated for acute venous thromboembolism.

Authors:  Jie Chen; Guoshan Bi; Fei Wu; Xiao Qin
Journal:  Pediatr Res       Date:  2022-09-07       Impact factor: 3.953

5.  Increasing rate of pulmonary embolism diagnosed in hospitalized children in the United States from 2001 to 2014.

Authors:  Shannon L Carpenter; Troy Richardson; Matt Hall
Journal:  Blood Adv       Date:  2018-06-26

6.  Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE).

Authors:  Katharina Thom; Anthonie W A Lensing; Ildar Nurmeev; Fanny Bajolle; Damien Bonnet; Gili Kenet; M Patricia Massicotte; Zeynep Karakas; Joseph S Palumbo; Paola Saracco; Pascal Amedro; Juan Chain; Anthony K Chan; Takanari Ikeyama; Joyce C M Lam; Cynthia Gauger; Ákos Ferenc Pap; Madhurima Majumder; Dagmar Kubitza; William T Smith; Scott D Berkowitz; Martin H Prins; Paul Monagle; Guy Young; Christoph Male
Journal:  Blood Adv       Date:  2020-10-13

7.  Efficacy of Early Prophylaxis Against Catheter-Associated Thrombosis in Critically Ill Children: A Bayesian Phase 2b Randomized Clinical Trial.

Authors:  E Vincent S Faustino; Veronika Shabanova; Leslie J Raffini; Sarah B Kandil; Simon Li; Matthew G Pinto; Jill M Cholette; Sheila J Hanson; Marianne E Nellis; Cicero T Silva; Ranjit Chima; Anjali Sharathkumar; Kimberly A Thomas; Tara McPartland; Joana A Tala; Philip C Spinella
Journal:  Crit Care Med       Date:  2021-03-01       Impact factor: 9.296

8.  Prevention of recurrent thrombotic events in children with central venous catheter-associated venous thrombosis.

Authors:  Helen Havens Clark; Lance Ballester; Hilary Whitworth; Leslie Raffini; Char Witmer
Journal:  Blood       Date:  2022-01-20       Impact factor: 25.476

9.  Acute Exposure to European Viper Bite in Children: Advocating for a Pediatric Approach.

Authors:  Marco Marano; Mara Pisani; Giorgio Zampini; Giuseppe Pontrelli; Marco Roversi
Journal:  Toxins (Basel)       Date:  2021-05-02       Impact factor: 4.546

10.  Age-Dependent Heterogeneity in the Efficacy of Prophylaxis With Enoxaparin Against Catheter-Associated Thrombosis in Critically Ill Children: A Post Hoc Analysis of a Bayesian Phase 2b Randomized Clinical Trial.

Authors:  E Vincent S Faustino; Leslie J Raffini; Sheila J Hanson; Jill M Cholette; Matthew G Pinto; Simon Li; Sarah B Kandil; Marianne E Nellis; Veronika Shabanova; Cicero T Silva; Joana A Tala; Tara McPartland; Philip C Spinella
Journal:  Crit Care Med       Date:  2021-04-01       Impact factor: 9.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.